In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Moderna (NASDAQ:MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...